Key result
ACE inhibitors can modify the ventricular remodeling process and may prevent genetically predetermined left ventricular hypertrophy in experimental animals.
Design
Review
Authors
Loading...
Does not support clinical use; leaves open translation of animal remodeling data to human genetic LVH.
Ventricular remodeling is a key pathophysiological process in heart failure that can be modified by therapies such as ACE inhibitors.
Bernhard Maisch (2008) conducted a review in Ventricular remodeling. ACE inhibitors was evaluated. ACE inhibitors can modify the ventricular remodeling process and may prevent genetically predetermined left ventricular hypertrophy in experimental animals.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: